SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013268
Filing Date
2022-08-11
Accepted
2022-08-11 16:06:00
Documents
74
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvlp-20220630x10q.htm   iXBRL 10-Q 1518221
2 EX-10.1 rvlp-20220630xex10d1.htm EX-10.1 1332560
3 EX-10.2 rvlp-20220630xex10d2.htm EX-10.2 150985
4 EX-10.3 rvlp-20220630xex10d3.htm EX-10.3 154552
5 EX-10.4 rvlp-20220630xex10d4.htm EX-10.4 134505
6 EX-10.5 rvlp-20220630xex10d5.htm EX-10.5 135832
7 EX-31.1 rvlp-20220630xex31d1.htm EX-31.1 11172
8 EX-32.2 rvlp-20220630xex32d2.htm EX-32.2 7900
  Complete submission text file 0001558370-22-013268.txt   8462881

Data Files

Seq Description Document Type Size
9 EX-101.SCH rvlp-20220630.xsd EX-101.SCH 49129
10 EX-101.CAL rvlp-20220630_cal.xml EX-101.CAL 62176
11 EX-101.DEF rvlp-20220630_def.xml EX-101.DEF 198226
12 EX-101.LAB rvlp-20220630_lab.xml EX-101.LAB 408027
13 EX-101.PRE rvlp-20220630_pre.xml EX-101.PRE 325744
68 EXTRACTED XBRL INSTANCE DOCUMENT rvlp-20220630x10q_htm.xml XML 992158
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38709 | Film No.: 221155666
SIC: 2834 Pharmaceutical Preparations